Literature DB >> 24255794

Corticosteroid monotherapy in a case of bronchocentric granulomatosis with a two-year follow-up.

Huiling Li1, Jianxing He, Yingying Gu, Nanshan Zhong.   

Abstract

Bronchocentric granulomatosis (BCG) is a rare disease. Because of the possibility of fungal infection, BCG has usually been treated with corticosteroids and antifungal agent. However, fungi are not detected in all BCG tissues. We report a case of proven BCG by open lung biopsy without fungi in a woman with corticosteroids monotherapy and two-year follow-up.

Entities:  

Keywords:  Bronchocentric granulomatosis (BCG); allergic disease; corticosteroids; fungal infection; open lung biopsy

Year:  2013        PMID： 24255794      PMCID： PMC3815734          DOI： 10.3978/j.issn.2072-1439.2013.10.13

Source DB:  PubMed          Journal:  J Thorac Dis        ISSN： 2072-1439            Impact factor:   2.895


  6 in total

1.  Pulmonary cavitation, allergic aspergillosis, asthma and bronchocentric granulomatosis.

Authors:  D H Goodman; J D Sacca
Journal:  Chest       Date:  1977-09       Impact factor: 9.410

Review 2.  The J. Burns Amberson lecture--pulmonary angiitis and granulomatosis.

Authors:  A A Liebow
Journal:  Am Rev Respir Dis       Date:  1973-07

3.  The structure of bronchial plugs in mucoid impaction, bronchocentric granulomatosis and asthma.

Authors:  T Jelihovsky
Journal:  Histopathology       Date:  1983-03       Impact factor: 5.087

4.  Bronchocentric granulomatosis: a complication of allergic bronchopulmonary aspergillosis.

Authors:  G Hanson; N Flor; I Wells; H Novey; S Galant
Journal:  J Allergy Clin Immunol       Date:  1977-01       Impact factor: 10.793

5.  Bronchocentric granulomatosis.

Authors:  M N Koss; R G Robinson; L Hochholzer
Journal:  Hum Pathol       Date:  1981-07       Impact factor: 3.466

6.  Bronchocentric granulomatosis and central diabetes insipidus successfully treated with corticosteroids.

Authors:  G P Rossi; E Pavan; M Chiesura-Corona; F Rea; A Poletti; A C Pessina
Journal:  Eur Respir J       Date:  1994-10       Impact factor: 16.671
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.